Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
overactive bladder
MedTech
FDA approves Medtronic's long-lasting neurostimulator implant
The FDA approved the newest version of the InterStim device, designed to go at least a decade without requiring recharging or replacement.
Andrea Park
Feb 25, 2022 11:26am
Bayer nixes midstage cough med weeks after Merck's was rejected
Feb 4, 2022 12:40pm
Urovant gets snapped up by Sumitovant Biopharma
Nov 13, 2020 11:37am
As Urovant preps vibegron launch, it’s all systems go on R&D
Aug 14, 2020 8:13am
Astellas alum Robinson takes the helm at Urovant
Mar 24, 2020 10:30am
FDA sets Dec. PDUFA date for Urovant rival to Astellas drug
Mar 6, 2020 8:40am